跳至主要内容
临床试验/ISRCTN12506329
ISRCTN12506329已完成未知

The effect of a pharmacist-led medication review on reduction of drug overuse and drug underuse in patients with an ADE-related hospital admission after ED visit compared to regular care

Erasmus MC0 个研究点目标入组 216 人开始时间: 2022年3月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Erasmus MC
入组人数
216

研究概览

简要总结

2022 Results article in https://doi.org/10.1186/s12913-022-08696-7 (added 22/05/2023) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39180043/ cost study (added 27/08/2024)

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients aged 18 years and older were eligible for inclusion if they were hospitalised for more than 24 hours after visiting the ED.

排除标准

  • 1. No communication possible due to condition or language barrier
  • 2. Cognitive impairment; transfers to other hospital
  • 3. No pre-admission medication; admission due to problems with cancer treatment
  • 4. Alcohol intoxication and/or (self)poisoning related hospitalisation
  • 5. Psychiatric hospitalisation
  • 6. Intensive care unit (ICU) hospitalisation
  • 7. Foreign tourist or homeless patient
  • 8. Already included patient readmitted within the research period
  • 9. Patients with no informed consent

研究者

发起方
Erasmus MC

相似试验